Prostate-specific antigen: Update 2006

被引:25
作者
Freedland, SJ
Partin, AW
机构
[1] Duke Univ, Med Ctr, Sch Med, Dept Surg,Div Urol, Durham, NC 27710 USA
[2] Johns Hopkins Sch Med, James Buchanan Brady Urol Inst, Dept Urol, Baltimore, MD USA
关键词
D O I
10.1016/j.urology.2005.12.026
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:458 / 460
页数:3
相关论文
共 12 条
  • [1] Preoperative PSA and progression-free survival after radical prostatectomy for stage T1c disease
    Antenor, JAV
    Roehl, KA
    Eggener, SE
    Kundu, SD
    Han, M
    Catalona, WJ
    [J]. UROLOGY, 2005, 66 (01) : 156 - 160
  • [2] LONGITUDINAL EVALUATION OF PROSTATE-SPECIFIC ANTIGEN LEVELS IN MEN WITH AND WITHOUT PROSTATE DISEASE
    CARTER, HB
    PEARSON, JD
    METTER, J
    BRANT, LJ
    CHAN, DW
    ANDRES, R
    FOZARD, JL
    WALSH, PC
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (16): : 2215 - 2220
  • [3] Pretreatment PSA velocity and risk of death from prostate cancer following external beam radiation therapy
    D'Amico, AV
    Renshaw, AA
    Sussman, B
    Chen, MH
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (04): : 440 - 447
  • [4] Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy
    D'Amico, AV
    Chen, MH
    Roehl, KA
    Catalona, WJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (02) : 125 - 135
  • [5] The prostatic specific antigen era is alive and well: Prostatic specific antigen and biochemical progression following radical prostatectomy
    Freedland, SJ
    Mangold, LA
    Walsh, PC
    Partin, AW
    [J]. JOURNAL OF UROLOGY, 2005, 174 (04) : 1276 - 1281
  • [6] Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy
    Freedland, SJ
    Humphreys, EB
    Mangold, LA
    Eisenberger, M
    Dorey, FJ
    Walsh, PC
    Partin, AW
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (04): : 433 - 439
  • [7] KURIYAMA M, 1980, Cancer Research, V40, P4658
  • [8] Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen
    Punglia, RS
    D'Amico, AV
    Catalona, WJ
    Roehl, KA
    Kuntz, KM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (04) : 335 - 342
  • [9] The prostate specific antigen era in the United States is over for prostate cancer: What happened in the last 20 years?
    Stamey, TA
    Caldwell, M
    McNeal, JE
    Nolley, R
    Hemenez, M
    Downs, J
    [J]. JOURNAL OF UROLOGY, 2004, 172 (04) : 1297 - 1301
  • [10] Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliter
    Thompson, IM
    Pauler, DK
    Goodman, PJ
    Tangen, CM
    Lucia, MS
    Parnes, HL
    Minasian, LM
    Ford, LG
    Lippman, SM
    Crawford, ED
    Crowley, JJ
    Coltman, CA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (22) : 2239 - 2246